Elanco, a division of Eli Lilly and Co. said today that Lilly has signed an agreement to acquire the worldwide rights to the dairy cow supplement, as well as the product’s supporting operations, from Monsanto. Elanco has exclusively sold the generic sometribove rBST outside of the United States for a decade.
“Global dairy demand is increasing, outstripping supply, and consumers are seeing rapidly rising prices,” said Jeff Simmons, president of Elanco. “With the purchase of Posilac, Elanco can enhance its overall product portfolio and work together with the industry to provide dairy farmers more options and give consumers affordable choices. Critically, we remain focused on the health and care of the cow in working with farmers to increase global milk supply.